Proposed Guideline on LMWHs in Biosimilars
The European Medicines Agency (EMA) announced on 31 January 2013 that it had released a draft guideline to revise the agency’s current guideline on biosimilars containing low molecular weight heparins (LMWHs), a type of medical product often used... more »
Aug 5, 2013 in Regulatory Affairs Blog